Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy

BACKGROUND: Isotretinoin, a teratogen, is widely used to treat cystic acne. Although the risks of pregnancy during isotretinoin therapy are well recognized, there are doubts about the level of adherence with the pregnancy prevention program in Canada. Our objective was to evaluate the effectiveness...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:CMAJ
Glavni autori: Henry, David, Dormuth, Colin, Winquist, Brandace, Carney, Greg, Bugden, Shawn, Teare, Gary, Lévesque, Linda E., Bérard, Anick, Paterson, J. Michael, Platt, Robert W.
Format: Artigo
Jezik:Inglês
Izdano: Joule Inc. 2016
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938682/
https://ncbi.nlm.nih.gov/pubmed/27114489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.151243
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items